79.50
-2.25 (-2.75%)
-2.25 (-2.75%)
Upgrade to Real-Time
Market Closed
Low
75.00
High
223.00
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Galapagos NV (GM) | GLPGF | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -2.25 | -2.75% | 79.50 | 14:21:59 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 79.50 | 79.50 | 79.50 | 79.50 | 81.75 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 81.75 | 81.75 | 0.00 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1 | 12 | $ 79.50 | $ 954 | - | 75.00 - 223.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:21:59 | 12 | $ 79.50 | USD |
Galapagos NV (GM) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.13B | 26.77M | - | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 138.84k | $ - | 0.00% | - | - |
Galapagos NV (GM) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLPGF Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 78.00 | 81.75 | 78.00 | 79.63 | 23 | 1.50 | 1.92% |
| 1 Month | 75.00 | 81.75 | 75.00 | 76.38 | 2,333 | 4.50 | 6.0% |
| 3 Months | 107.00 | 110.10 | 75.00 | 93.84 | 4,399 | -27.50 | -25.7% |
| 6 Months | 130.4898 | 130.4898 | 75.00 | 98.90 | 6,426 | -50.99 | -39.08% |
| 1 Year | 212.00 | 223.00 | 75.00 | 100.25 | 4,014 | -132.50 | -62.5% |
| 3 Years | 98.50 | 276.21 | 75.00 | 152.62 | 4,955 | -19.00 | -19.29% |
| 5 Years | 41.63 | 276.21 | 41.63 | 128.36 | 4,997 | 37.87 | 90.97% |
Galapagos NV (GM) Description
| Galapagos is a midsized biotechnology company, with therapeutic programs based on proprietary disease modifying drug targets, and a focus on inflammation, orphan disease, and anti-infectives. Galapagos' approach is to develop drugs that stop or reverse a disease state using novel targets that are identified through a patent protected target discovery platform. Galapagos also provides access to its target and drug discovery platform through its services division, BioFocus and Argenta, which offers a full suite of target-to-drug discovery products and services to pharmaceutical and biotech companies. |
